학술논문
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy
Document Type
Article
Author
Praga, Manuel; Sevillano, Angel; Caravaca-Fontan, Fernando; Trujillo, Hernando; Gutiérrez, Eduardo; Juarez, Gema Fernandez; Shabaka, Amir; Rojas-Rivera, Jorge; Egido, Jesus; Ortiz, Alberto; Goicoechea, Marian; Verdalles, Úrsula; Segarra, Alfons; Agraz, Irene; Martín-Reyes, Guillermo; Perea, Lara; Valera, Ildefonso; Martín, Mónica; Cabello, Virginia; Pérez Valdivia, Miguel Angel; Quintana, Luis F.; Blasco, Miquel; Cao, Mercedes; Muñiz, Andrés López; Avila, Ana; Malek, Tamara; Espinosa, Mario; Rabasco, Cristina; Diaz, Montserrat; DaSilva, Iara; Bonet, Jordi; Navarro, Maruja; Gómez-Martino, Juan Ramón; Rivas, Begoña; Rodríguez-Moreno, Antolina; Galeano, Cristina; Romera, Ana; Huerta, Ana; Rodríguez-Paternina, Ezequiel; Vigil, Ana; Alcázar, Roberto; Paraíso, Vicente; Barrio, Vicente; Wetzels, Jack; Logt, Anne-Els van de; Hofstra, Julia; Fernández-Juárez, Gema; Justino, Joana; Caravaca-Fontán, Fernando; Ávila, Ana; Varela, Alfonso; Díez, Montserrat; Diezhandino, Marian Goicoechea; Bonet, Jose; Plaisier, Emmanuelle; Segarra, Alfonso; Lambeau, Gérard; Ronco, Pierre
Source
In Kidney International April 2021 99(4):986-998
Subject
Language
ISSN
0085-2538